Discover what’s new in our AI radiology solutions
Disease Modifying Therapies NeuroQuant, Cortechs.ai’s advanced AI-driven brain volumetric analysis software, is elevating Alzheimer’s disease (AD) care, according to Suzie […]
NeuroQuant MS sets a new standard in the assessment of multiple sclerosis (MS) on brain MRI, leveraging advanced AI-powered deep
Epilepsy is one of the most common neurological disorders worldwide, affecting millions of people with unpredictable, life-altering seizures. While advancements
“I can’t remember life without NeuroAlign CT, and frankly I don’t want to!” NeuroAlign CT sets a new standard in
As the incidence of prostate cancer continues to rise globally, the need for advanced diagnostic tools has become increasingly urgent.
NeuroQuant Brain Tumor is an FDA-cleared software solution designed to provide radiologists with accurate, automated measurements of brain tumors. By
In the evolving landscape of medical diagnostics, neuroimaging plays a critical role in understanding brain disorders, from Alzheimer’s to traumatic
The recently updated “Alzheimer’s Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for ARIA Monitoring” 2024 guidelines for monitoring Amyloid-Related
Introduction On-Demand Prior Processing v4.1 by Cortechs.ai marks a significant leap to improve longitudinal analysis of NeuroQuant studies. This blog
Microvascular ischemic disease (MVID), also known as cerebral small vessel disease, is a brain condition predominantly affecting older individuals, with
In the realm of medical research, the development of cutting-edge technologies has revolutionized our understanding and treatment of various diseases.
San Diego, CA – Cortechs.ai, a pioneer in AI-driven healthcare solutions, proudly announces a major update for its flagship product,
5060 Shoreham Place,
Ste 240, San Diego, CA 92122
